BDC-3042
Bolt Therapeutics
[]
join the #boltbio team at the 37th annual society for immunotherapy of cancer meeting (#sitc22) for an update on bdc-3042 targeting dectin-2, an agonistic antibody for solid tumors. abstract number 1348, poster hall c. learn more about bdc-3042: 